
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:title>Acute and Short-Term Effects of a New Calcium Antagonist in Hypertension</dc:title>
  <dc:subject>Hypertension</dc:subject>
  <dc:subject>Antihypertensive Agents</dc:subject>
  <dc:subject>Calcium Channel Blockers</dc:subject>
  <dc:subject>Nitrendipine</dc:subject>
  <dc:description>Freis and his team continued to run clinical trials late in to his career, assessing the newer hypertension drugs as they were developed. In this article, they reported that an early trial on nitrendipine, a calcium channel blocker, indicated that it was an effective antihypertensive agent with minor side-effects.</dc:description>
  <dc:publisher>American Heart Association, [May-June 1982]</dc:publisher>
  <dc:publisher>The American Heart Association, [May-June 1982]</dc:publisher>
  <dc:contributor>Hypertension</dc:contributor>
  <dc:contributor>Blood Pressure Council</dc:contributor>
  <dc:contributor>Burris, James F.</dc:contributor>
  <dc:contributor>Notargiacomo, Aldo V.</dc:contributor>
  <dc:contributor>Papademetriou, Vasilios</dc:contributor>
  <dc:contributor>Freis, Edward D.</dc:contributor>
  <dc:type>Articles</dc:type>
  <dc:format>Archival Materials</dc:format>
  <dc:format>Text</dc:format>
  <dc:format>4 pages</dc:format>
  <dc:identifier>nlm:nlmuid-101584929X22-doc</dc:identifier>
  <dc:identifier>101584929X22</dc:identifier>
  <dc:identifier>http://resource.nlm.nih.gov/101584929X22</dc:identifier>
  <dc:identifier>Profiles ID: XFBBCB</dc:identifier>
  <dc:language>English</dc:language>
  <dc:relation>Profiles in Science</dc:relation>
</oai_dc:dc>